Skip to main content
. 2020 Oct 4;26:661–669.

Table 1. Baseline characteristics of all subjects.

Baseline characteristics No EMD EMD p-value
Number of patients, n
912
608
 
Female sex, n (%)
440 (48.2%)
454 (74.7%)
p<0.001*
Age (years), mean ±SD
71.20±10.17
74.51±8.02
p<0.001 *
AMD status
 
 
p<0.001*
No AMD, n (%)
623 (68.3%)
134 (22.0%)
 
Early/intermediate AMD, n (%)
158 (17.3%)
188 (30.9%)
 
Late AMD, n (%)
131 (14.4%)
286 (47.0%)
 
C3d/C3 Ratio (ln), mean ±SD
1.41±0.40
1.51±0.40
p<0.001†
Ever smoked, n (%)
482 (52.85%)
257 (42.27%)
p<0.001*
Hypertension, n (%)
299 (32.79%)
204 (33.55%)
p=0.220*
Cardiovascular diseases, n (%)
154 (16.89%)
97 (15.95)
p=0.525*
BMI ≥25, n (%)
497 (54.50%)
289 (47.53%)
p=0.023*
Diabetes, n (%)
77 (8.44%)
47 (7.73%)
p=0.561*
Allergy, n (%)
177 (19.41%)
111 (18.26%)
p=0.484*
Sunlight exposure ≥8h, n (%)
82 (8.99%)
96 (15.79%)
p<0.001*
Total cholesterol (mmol/l), mean ±SD
5.71±1.22
5.91±1.16
p=0.003†
HDL cholesterol (mmol/l), mean ±SD
1.42±0.37
1.56±0.37
p<0.001†
Triglyceride (mmol/l), mean ±SD 1.96±0.99 1.72±0.89 p<0.001†

AMD: Age-related macular degeneration, BMI: Body mass Index, EMD: Extramacular drusen, HDL: High density lipoprotein, *Chi-square Test, † Mann–Whitney-U Test, In: natural logarithm of.